GetTopicDetailResponse(id=c84513800b8, topicName=Patisiran, introduction=Patisiran, content=null, image=null, comments=3, allHits=1051, url=https://h5.medsci.cn/topic?id=13800, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=77369, tagList=[TagDto(tagId=77369, tagName=Patisiran)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1515234, encodeId=58bd151523435, content=<a href='/topic/show?id=c84513800b8' target=_blank style='color:#2F92EE;'>#Patisiran#</a>, objectTitle=Lancet Neurology：Patisiran治療遺傳性甲狀腺素運(yùn)載蛋白介導(dǎo)的多發(fā)性神經(jīng)病性淀粉樣變的長(zhǎng)期安全性和有效性結(jié)果 , objectType=article, longId=206032, objectId=5a4220603291, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a4220603291, replyNumber=0, likeNumber=105, createdTime=2021-01-23, rootId=0, userName=ms3892185887221420, userId=7bf910741604, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a4220603291, moduleTitle=Lancet Neurology：Patisiran治療遺傳性甲狀腺素運(yùn)載蛋白介導(dǎo)的多發(fā)性神經(jīng)病性淀粉樣變的長(zhǎng)期安全性和有效性結(jié)果 , moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5a4220603291)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515233, encodeId=20fc151523353, content=<a href='/topic/show?id=c84513800b8' target=_blank style='color:#2F92EE;'>#Patisiran#</a>, objectTitle=Lancet Neurol：Patisiran治療遺傳性轉(zhuǎn)甲狀腺素蛋白淀粉樣變性長(zhǎng)期效果及安全性研究, objectType=article, longId=203514, objectId=468e203514a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=468e203514a5, replyNumber=0, likeNumber=103, createdTime=2020-11-19, rootId=0, userName=ms3892185887221420, userId=7bf910741604, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=468e203514a5, moduleTitle=Lancet Neurol：Patisiran治療遺傳性轉(zhuǎn)甲狀腺素蛋白淀粉樣變性長(zhǎng)期效果及安全性研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=468e203514a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515232, encodeId=c1ea151523277, content=<a href='/topic/show?id=c84513800b8' target=_blank style='color:#2F92EE;'>#Patisiran#</a>, objectTitle=**RNAi藥物patisiran有望近期上市, objectType=article, longId=113627, objectId=9c3d11362efe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c3d11362efe, replyNumber=0, likeNumber=89, createdTime=2017-09-23, rootId=0, userName=ms3892185887221420, userId=7bf910741604, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c3d11362efe, moduleTitle=**RNAi藥物patisiran有望近期上市, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9c3d11362efe)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
